David Wormser
Overview
Explore the profile of David Wormser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
2544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanson G, Chitnis T, Williams M, Gan R, Julian L, Mace K, et al.
JAMIA Open
. 2022 Feb;
5(1):ooab110.
PMID: 35155999
Objective: The FlywheelMS study will explore the use of a real-world health record data set generated by PicnicHealth, a patient-centric health records platform, to improve understanding of disease course and...
2.
Butzkueven H, Spelman T, Horakova D, Hughes S, Solaro C, Izquierdo G, et al.
Eur J Neurol
. 2021 Mar;
29(4):1082-1090.
PMID: 33724638
Background And Purpose: Reaching Expanded Disability Status Scale (EDSS) ≥7.0 represents the requirement for a wheelchair. Here we (i) assess the effect of ocrelizumab on time to EDSS ≥7.0 over...
3.
Dirks P, Zingler V, Leemhuis J, Berthold H, Hieke-Schulz S, Wormser D, et al.
BMC Neurol
. 2020 Mar;
20(1):95.
PMID: 32171264
Background: Multiple sclerosis (MS) is a chronic disease that requires lifelong treatment. A highly effective drug not only for relapsing but also for progressive forms of MS with a favorable...
4.
Smith K, Burkill S, Hiyoshi A, Olsson T, Bahmanyar S, Wormser D, et al.
Mult Scler
. 2020 Mar;
27(2):268-280.
PMID: 32162580
Background: People with multiple sclerosis (pwMS) have increased comorbid disease (CMD) risk. Most previous studies have not considered overall CMD burden. Objective: To describe lifetime CMD burden among pwMS. Methods:...
5.
Krueger W, Anthony M, Saltus C, Margulis A, Rivero-Ferrer E, Monz B, et al.
Drugs Real World Outcomes
. 2017 Jul;
4(3):139-149.
PMID: 28756575
Background: Regulatory agencies often request prospective, product-specific post-authorization pregnancy exposure registries to monitor safety during pregnancy, even though studies using existing health databases could also be employed. Objectives: Using multiple...
6.
Wormser D, Chen D, Brunetta P, Sun D, Broder M, Chang E, et al.
J Am Acad Dermatol
. 2017 Jul;
77(2):379-381.
PMID: 28711092
No abstract available.
7.
Global BMI Mortality Collaboration , Di Angelantonio E, Bhupathiraju S, Wormser D, Gao P, Kaptoge S, et al.
Lancet
. 2016 Jul;
388(10046):776-86.
PMID: 27423262
Background: Overweight and obesity are increasing worldwide. To help assess their relevance to mortality in different populations we conducted individual-participant data meta-analyses of prospective studies of body-mass index (BMI), limiting...
8.
Stevens J, Erber-Oakkar E, Cui Z, Cai J, Virani S, Di Angelantonio E, et al.
Obesity (Silver Spring)
. 2016 May;
24(7):1554-60.
PMID: 27184463
Objective: The 1998 and the 2013 guidelines on management of overweight and obesity in adults provided algorithms for identification of patients to be treated with weight loss. To date, the...
9.
Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth A, Bansal N, et al.
JAMA
. 2015 Jul;
314(1):52-60.
PMID: 26151266
Importance: The prevalence of cardiometabolic multimorbidity is increasing. Objective: To estimate reductions in life expectancy associated with cardiometabolic multimorbidity. Design, Setting, And Participants: Age- and sex-adjusted mortality rates and hazard...
10.
Wormser D, Wood A, Di Angelantonio E, Thompson S, Danesh J
Lancet
. 2014 Jun;
383(9934):2042-2043.
PMID: 24931685
No abstract available.